What is NuvaRing?
NuvaRing, manufactured by Organon, Schering-Plough, and Merck is the trade name for a combined hormonal contraceptive vaginal ring used for birth control. It contains ethinyl estradiol and etonogestrel, a metabolite of desogestrel, which has been recognized as a possibly dangerous progestin. NuvaRing has been associated with adverse side effects such as:
- Blood Clots
- Heart Attack
- Deep Vein Thrombosis
- Myocardial Infarction
- Cerebrovascular Accidents
- Pulmonary Embolism
Women across the United States who suffered serious side effects have looked at filing a Nuvaring lawsuit. NuvaRing birth control is a third generation contraceptive manufactured by Organon USA. Organon is part of the Schering-Plough Corporation. Nuva Ring birth control is a flexible polyethylene ring that contains estrogen and a form of the progestin desogestrel. NuvaRing is considered a combination hormonal contraceptive. Currently claims are being made individually and no national Nuvaring class action has been filed.
NuvaRing birth control was approved by the Federal Drug Administration (FDA) in October 2001. It was first marketed in the United States in July 2002. Nuva Ring is used by over 1.5 million women around the world. Third generation contraceptives such as NuvaRing were initially developed in the 1980’s to have fewer adverse effects such as weight gain, hirsutism, and acne.
How Does Nuva Ring Work?
NuvaRing contains a combination of estrogen and progestin hormones. The hormones are released in a low steady dose directly into the bloodstream by being absorbed through the vaginal wall. Nuvaring birth control is worn for three weeks and then removed for one week. It prevents the ovaries from producing an egg. The lining of the uterus also becomes thinner inhibiting a fertilized egg from being implanted. In addition, the cervical mucous becomes thicker which helps prevent sperm from entering the uterus.
Since Nuva Ring birth control is a relatively new form of contraceptive there are few studies regarding its safety and effectiveness. As early as 1995 studies had shown there was an increased risk of venous thrombosis (blood clots) in contraceptives containing desogestrel compared to second generation birth control that contained other types of progestins. The FDA acknowledged this in November 1995 stating “new studies indicate about a two-fold increase in the risk of venous blood clots associated with products containing desogestrel.” If blood clots form in your legs they can travel to the lungs and causes blockages. Blood clots can also from in the eye causing partial vision loss or blindness.
NuvaRing Birth Control Lawsuit
If you or a loved one has suffered side effects of NuvaRing birth control such as stroke, blood clot or heart attack you may be able to file a Nuva Ring lawsuit. Our Nuva Ring birth control attorneys can help evaluate your claim. Free initial consultation. No fees unless we recover compensation for you. Protecting the rights of women suffering from side effects of NuvaRing nationwide in all 50 states.